RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25

about

RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25

Item

http://www.wikidata.org/entity/Q41247591

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25

@en

type

Item

label

RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25

@en

prefLabel

RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25

@en

P1476

RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25

@en

P2093

Bing Liao

http://www.w3.org/2001/XMLSchema#string

Jin-Huan Wei

http://www.w3.org/2001/XMLSchema#string

Jun Lu

http://www.w3.org/2001/XMLSchema#string

Jun-Jie Cen

http://www.w3.org/2001/XMLSchema#string

Liang-Yun Zhao

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Yan-Ping Liang

http://www.w3.org/2001/XMLSchema#string

Yi-Hui Pan

http://www.w3.org/2001/XMLSchema#string

Yong Fang

http://www.w3.org/2001/XMLSchema#string

Yong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration

Protein binding and signaling properties of RIN1 suggest a unique effector function

The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins.

Regulation of vesicle trafficking in madin-darby canine kidney cells by Rab11a and Rab25

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Association of Rab25 and Rab11a with the apical recycling system of polarized Madin-Darby canine kidney cells

Cancer statistics, 2016

ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell.

Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms.

Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.

P304

1620-1627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Jun-Hang Luo

P577

2017-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28612496

http://www.w3.org/2001/XMLSchema#string

P932

5543468

http://www.w3.org/2001/XMLSchema#string